Body size and risk of epithelial ovarian cancer (United States)

Cancer Causes & Control : CCC
Mary Anne RossingNoel S Weiss

Abstract

We conducted a population-based case-control study of epithelial ovarian cancer in relation to measures of body size and adult weight change. In particular, we sought to characterize the independent relation of body weight at particular ages with risk. In-person interviews were sought with 35-54 year-old female residents of metropolitan Atlanta, Seattle or Detroit diagnosed with ovarian cancer during 1994-1998, and with controls sampled from these populations. Information provided by 355 cases and 1,637 controls was analyzed using unconditional logistic regression. The risk among women in the top tenth, relative to women in the lowest fourth, of the distribution of body weight at age 18 years was 1.5 (95% confidence interval, 1.0-2.2); at age 30, 1.9 (1.2-2.9); and 5 years before the reference date, it was 2.1 (1.4-3.3). While our results did not substantiate risk elevations reported in previous studies among subsets of women (e.g., with particular histologic tumor subtypes or according to past oral contraceptive use), we noted a particularly increased risk among women who reported 10 or more pounds gained during their first year of oral contraceptive use. Our findings suggest that risk of epithelial ovarian cancer may be most ...Continue Reading

References

Jun 1, 1991·The American Journal of Clinical Nutrition·V A CaseyI Valadian
Dec 1, 1990·American Journal of Epidemiology·J StevensP C Gazes
Apr 20, 2001·The Proceedings of the Nutrition Society·T J KeyE Banks
Aug 14, 2001·Obesity Research·C KoprowskiL Bernstein
Nov 21, 2001·Cancer Causes & Control : CCC·D M PurdieA C Green
Feb 5, 2002·Pituitary·F P Pralong, R C Gaillard
Mar 2, 2002·Fertility and Sterility·Stergios MoschosChristos S Mantzoros
May 4, 2002·Annals of Epidemiology·Polly A MarchbanksRobert Spirtas
May 7, 2002·International Journal of Cancer. Journal International Du Cancer·Annekatrin LukanovaRudolf Kaaks
Aug 2, 2002·Obstetrics and Gynecology·Kathleen M FairfieldSusan E Hankinson
Aug 15, 2002·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·L Dal MasoC La Vecchia
Jan 11, 2003·American Journal of Epidemiology·F LubinB Modan
Mar 5, 2003·American Journal of Epidemiology·Leo J SchoutenPiet A van den Brandt
Jul 8, 2003·International Journal of Cancer. Journal International Du Cancer·Fredrik JonssonMaria Feychting
Aug 21, 2003·Journal of the National Cancer Institute·Anders EngelandTone Bjørge
Nov 25, 2004·American Journal of Epidemiology·Mary Anne RossingKristine G Wicklund

❮ Previous
Next ❯

Citations

Oct 16, 2012·Cancer Causes & Control : CCC·Dada SuAndy H Lee
Jul 17, 2009·American Journal of Epidemiology·Patricia G MoormanJoellen M Schildkraut
Apr 3, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Leo J SchoutenStephanie A Smith-Warner
May 19, 2012·PLoS Medicine·UNKNOWN Collaborative Group on Epidemiological Studies of Ovarian Cancer
Aug 19, 2007·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Manuel Neves-E-Castro
Jan 10, 2008·International Journal of Cancer. Journal International Du Cancer·Sabine SieslingUNKNOWN Working Group of The Netherlands Cancer Registry
Oct 13, 2009·International Journal of Cancer. Journal International Du Cancer·Petra H LahmannElio Riboli
Aug 7, 2012·The Lancet Oncology·UNKNOWN Collaborative Group on Epidemiological Studies of Ovarian CancerR Peto
Oct 23, 2015·Japanese Journal of Clinical Oncology·Zhen LiuQing-Bao Tian
Jul 20, 2017·Post Reproductive Health·Ke Wei Foong, Helen Bolton

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology
Leo J SchoutenStephanie A Smith-Warner
© 2022 Meta ULC. All rights reserved